Abstract:YAP1 is a key mediator of the Hippo pathway capable of exerting a profound effect on organ size as well as tumorigenesis. Alternative mRNA splicing of human YAP1 results in at least 8 protein isoforms that differ within the 2nd WW motif and the transcriptional activation domain. Methods: To investigate the isoform-specific differences in their mRNA expression, transcriptional activity and tumor-promoting function, we cloned cDNA encoding all of the eight YAP1 protein isoforms. Then, we examined their mRNA expression, subcellular localization, transcriptional regulation properties, interactions with key regulatory partners, and protein stability in response to changes in cell density, as well as their effects on pancreatic cancer cell malignancy both in vitro and in vivo. Results: Multiple YAP1 mRNA isoforms are expressed in commonly used pancreatic cancer lines as well as human pancreatic cancer PDX lines. Based on the analysis of heterologous reporter and endogenous target genes, all YAP1 isoforms are capable of activating transcription, albeit to a different extent. Importantly, we unveiled a marked discrepancy between the mRNA and protein expression levels of the YAP1-1 and YAP1-2 isoforms. We further discovered that the YAP1-2 isoform, which contains two tandem WW motifs, is less stable at the protein level, particularly at high cell densities. Mechanistically, we found that the presence of the 2nd WW motif in YAP1-2 facilitates the de novo formation of the YAP1-2/AMOT/LATS1 complex and contributes to a stronger binding of YAP1-2 to LATS1 and subsequently increased YAP1-2 ubiquitination and degradation by beta-TRCP. Conclusion: Our data reveals a potent effect of YAP1-1 on pancreatic cancer malignancy in vitro and in vivo and provides novel mechanistic insight into isoform-specific and cell density-dependent regulation of YAP1 stability, as well as its impact on cancer malignancy.

Identification and Functional Comparison of Novel Alternatively Spliced Isoforms of Human YAP

Identification, subcellular localization, and functional comparison of novel Yap splicing isoforms in mouse embryonic stem cells

The Role of YAP Transcription Coactivator in Regulating Stem Cell Self-Renewal and Differentiation.

TEAD Mediates YAP-dependent Gene Induction and Growth Control

Quantitative Real-Time PCR to Measure YAP/TAZ Activity in Human Cells.

A Coordinated Phosphorylation By Lats And Ck1 Regulates Yap Stability Through Scf Beta-Trcp

Structural Insights into the YAP and TEAD Complex.

SET1A-Mediated Mono-Methylation at K342 Regulates YAP Activation by Blocking Its Nuclear Export and Promotes Tumorigenesis.

The WW domains dictate isoform-specific regulation of YAP1 stability and pancreatic cancer cell malignancy

Harness the power: new insights into the inhibition of YAP/Yorkie.

Structural Basis of YAP Recognition by TEAD4 in the Hippo Pathway.

Inactivation of Yap Oncoprotein by the Hippo Pathway is Involved in Cell Contact Inhibition and Tissue Growth Control

The Hippo-YAP Pathway in Organ Size Control and Tumorigenesis: an Updated Version.

The Hippo Pathway Effector Proteins YAP and TAZ Have Both Distinct and Overlapping Functions in the Cell

Angiomotin is a Novel Hippo Pathway Component That Inhibits YAP Oncoprotein.

Yes-Associated Protein Impacts Adherens Junction Assembly Through Regulating Actin Cytoskeleton Organization

The Regulation and Function of YAP Transcription Co-Activator

Integration of Mechanical and Chemical Signals by YAP and TAZ Transcription Coactivators.

Figure S1 to S13 from YAP is Essential for Treg-Mediated Suppression of Antitumor Immunity

Expression levels and activation status of Yap splicing isoforms determine self-renewal and differentiation potential of embryonic stem cells

Structural and Functional Analysis of the YAP-binding Domain of Human TEAD 2